RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Danno cardio-vascolare precoce in bambini ed adolescenti obesi :la identificazione di markers di rischio metabolici e/o genetici rende possibile la diagnosi precoce e può migliorare la qualità della vita futura.
• 2 - Nuovi modelli animali per lo studio dei meccanismi molecolari di malattia comuni a diabete mellito di tipo 2 e aterosclerosi
• 3 - Ruolo di citochine ed ormoni di origine gastrointestinale ed adipocitaria nella patogenesi dell'obesità e delle sue complicanze
• 4 - OBESITA' E SINDROME METABOLICA: CARATTERIZZAZIONE FENOTIPICA E IMPLICAZIONI PATOGENETICHE
• 5 - PEROSSIDAZIONE LIPIDICA, ATTIVAZIONE PIASTRINICA ED INFIAMMAZIONE ASSOCIATI A RIDOTTI LIVELLI DI LIPOPROTEINE AD ALTA DENSITA' (HDL)
• 6 - Ricerca dei fattori genetici responsabili della suscettibilità al diabete autoimmune e comprensione delle loro conseguenze funzionali
• 7 - DISSEZIONE DEI FATTORI GENETICI E COMPRENSIONE DEI MECCANISMI RESPONSABILI DEL DIABETE AUTOIMMUNE
• 8 - Interruttori molecolari che controllano l'omeostasi dei sistemi metabolici e vascolari: dai modulatori del RNA a quelli della trasmissione del segnale
• 9 - Meccanismi patogenetici che condizionano l'espressione fenotipica dell'obesità e la risposta alla terapia
• 10 - Iperlipidemia, Aterosclerosi e Insufficienza Renale

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA
  • PEDIATRIA GENERALE E SPECIALISTICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Veneto

Bibliografia

1. World Health Organization. Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, 3-5 June 1997.
2. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obes Rev. 2003;4(4):195-200.
3. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997;337(13):869-73.
4. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease.
Pediatrics 1998;101(3 Pt 2):518-25.
5. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-810.
6. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA. 1990;264(19):2519-23
7. Molnar D. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord. 2004;28 Suppl 3:S70-4.
8. Snyder EE, Walts B, Perusse L, Chagnon YC, Weisnagel SJ, Rankinen T, Bouchard C. The human obesity gene map: the 2003 update. Obes Res. 2004;12(3):369-439.
9. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182, 2003
10. Park BH, et al.: Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol. 2004;24(19):8671-80.
11. Bluher M, Wilson-Fritch L, Leszyk J, Laustsen PG, Corvera S, Kahn CR Role of insulin action and cell size on protein expression patterns in adipocytes. J Biol Chem. 2004 Jul 23;279(30):31902-9.
12. Boudreau NJ, Jones PL. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J. 1999;339 ( Pt 3):481-8.
13. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
14. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111(11):1448-54.
15. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 138:S419-420, 1999
16. Ridker PM, Morrow DA: C-reactive protein, inflammation, and coronary risk. Cardiol Clin 21:315-325, 2003
17. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192, 2002
18. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF: Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107:181-189, 2001
19. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA: Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52:2784-2789, 2003
20. Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS: Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 88:627-636, 2003
21. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children.
J Clin Endocrinol Metab. 2004;89(8):3790-4
22. Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, Machicao F, Haring H. Associationof the T-G polymorphism in adiponectin with obesity and insulin sensitivity. Interactionwith family history of type 2 diabetes. Diabetes 2002;51:37-41
23. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002;51:536-540
24. Gibson F, Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in Frenche caucasians. Diabetes 2004;53:2977-2983
25. Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group. The common polymorphisms (single nucleotide polymorphisms [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes. The STOP-NIDDM trial. Diabetes 2005;54:893-899
26. Shoelson SE, Lee J, Yuan M: Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27 Suppl 3:S49-52, 2003
27. Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M: FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab 87:2913-2917, 2002
28. Gokce N, Keaney JF, Jr., Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41:1769-1775, 2003
29. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H: Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7:395-403, 2005
30. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374, 2004

Parole Chiave

OBESITÀ, BAMBINO, GENI, METABOLISMO